Mette Rosenkilde

Mette Rosenkilde

Professor

Member of:


    1. 2020
    2. Published

      Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist

      Willard, F. S., Douros, J. D., Gabe, M., Showalter, A. D., Wainscott, D. B., Suter, T. M., Capozzi, M. E., van der Velden, W. J. C., Stutsman, C., Cardona, G. R., Urva, S., Emmerson, P. J., Holst, Jens Juul, D'Alessio, D. A., Coghlan, M. P., Rosenkilde, Mette, Campbell, J. E. & Sloop, K. W., 2020, In: JCI insight. 5, 17, 16 p., 140532.

      Research output: Contribution to journalJournal articlepeer-review

    3. Published

      The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson's Disease

      Zhang, L., Zhang, L., Li, Y., Li, L., Melchiorsen, J. U., Rosenkilde, Mette & Holscher, C., 2020, In: Journal of Parkinson's Disease. 10, 2, p. 523-542

      Research output: Contribution to journalJournal articlepeer-review

    4. Published

      Perspective: Implications of Ligand-Receptor Binding Kinetics for Therapeutic Targeting of G Protein-Coupled Receptors

      van der Velden, W. J. C., Heitman, L. H. & Rosenkilde, Mette, 2020, In: ACS Pharmacology & Translational Science. 3, 2, p. 179-189 11 p.

      Research output: Contribution to journalJournal articlepeer-review

    Previous 1 2 3 Next

    ID: 3361